Market Overview The harringtonine market is experiencing development as this natural alkaloid demonstrates efficacy in acute myeloid leukemia and other hematologic malignancies. The global market is projected to exceed USD 2.8 billion through 2030, driven by leukemia prevalence, treatment-resistant disease targeting, and clinical trial advancement. Harringtonine treats leukemia through protein...